Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Frederick

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The International Migration Review|April 1, 1984
Colombian emigration: a research note on its probable quantitative extentS Diaz-briquets, M J Frederick
Expert Reviews in Molecular Medicine|October 31, 2003
Chemokines in cancerM J Frederick, G L Clayman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neckD K Frank, M J Frederick, T J Liu, et al.
Cancer Research|January 1, 1996
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteinsM J Frederick, L V Rodriguez, D A Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neckD K Frank, T J Liu, M J Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell deathM J Frederick, P R Holton, M Hudson, et al.
Immunopharmacology|November 1, 1996
Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cellsM J Frederick, T K Yu, E G Krohn, et al.
Cancer Research|January 1, 1996
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastinM J Frederick, L V Rodriguez, D A Johnston, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cellsT Nakashima, S C Pak, G A Silverman, et al.
Biochemistry|October 21, 2000
Characterization of human copine III as a phosphoprotein with associated kinase activityE G Caudell, J J Caudell, C H Tang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The International Migration Review|April 1, 1984
Colombian emigration: a research note on its probable quantitative extentS Diaz-briquets, M J Frederick
Expert Reviews in Molecular Medicine|October 31, 2003
Chemokines in cancerM J Frederick, G L Clayman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neckD K Frank, M J Frederick, T J Liu, et al.
Cancer Research|January 1, 1996
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteinsM J Frederick, L V Rodriguez, D A Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neckD K Frank, T J Liu, M J Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell deathM J Frederick, P R Holton, M Hudson, et al.
Immunopharmacology|November 1, 1996
Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cellsM J Frederick, T K Yu, E G Krohn, et al.
Cancer Research|January 1, 1996
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastinM J Frederick, L V Rodriguez, D A Johnston, et al.
Biochimica Et Biophysica Acta|September 27, 2000
Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cellsT Nakashima, S C Pak, G A Silverman, et al.
Biochemistry|October 21, 2000
Characterization of human copine III as a phosphoprotein with associated kinase activityE G Caudell, J J Caudell, C H Tang, et al.
Pageof 2